Article info

Download PDFPDF
Original research
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study

Authors

  1. Correspondence to Dr Sailish Honap, IBD Centre, 1st Floor College House, Westminster Bridge Road, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK; shonap{at}nhs.net
View Full Text

Citation

Honap S, Al-Hillawi L, Baillie S, et al
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study

Publication history

  • Received March 14, 2022
  • Accepted April 18, 2022
  • First published April 28, 2022.
Online issue publication 
October 07, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.